南京毓浠医药技术

Yuxi Pharmaceutical is a clinical-stage biotechnology company based in Nanjing, China, specializing in the development of innovative topical and transdermal therapies for dermatological conditions. The company leverages its proprietary drug delivery platforms to create high-concentration, stable, and skin-permeable formulations of proven active ingredients. Its pipeline includes treatments for atopic dermatitis, psoriasis, and alopecia areata, with lead candidates currently in Phase 2 clinical trials. Yuxi Pharmaceutical aims to address unmet medical needs in dermatology by improving the efficacy and safety profiles of existing treatments through advanced formulation science. The company is supported by leading venture capital firms including Sequoia China and Sherpa Healthcare Partners.